AEON Biopharma, Inc.
AEON
$0.88
$0.00-0.23%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -193.37% | -100.02% | 99.46% | 134.87% | 110.92% |
| Total Depreciation and Amortization | -19.59% | -17.35% | -13.00% | -8.08% | -2.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 145.61% | 73.41% | -103.51% | -141.47% | -118.59% |
| Change in Net Operating Assets | -1,083.14% | 36.95% | 67.91% | -63.42% | 125.78% |
| Cash from Operations | 14.71% | 56.93% | 68.72% | 56.79% | 57.57% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -100.00% | -100.00% | -23.08% | 7.14% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 12,494.56% | 37,122.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 34.05% | 23.66% | 23.85% | 119.18% | 8.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 158.17% | 134.46% | 117.60% | 127.46% | 84.79% |